Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03195699
Title Phase I Study of Oral STAT3 Inhibitor, C188-9, in Patients With Advanced Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors StemMed, Ltd., USA
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Mays Cancer Center at University of Texas Health Science Center SA San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field